Group 1 - The company, Hongji Chuangneng Technology, submitted its Hong Kong IPO prospectus on June 27, which became invalid after six months on December 27, with Haitong International and CITIC Securities as joint sponsors [1] - According to the prospectus, the company claims to be a global leader in independent membrane electrode supply, focusing on the R&D, mass production, and commercialization of catalyst-coated membranes (CCM) and membrane electrode assemblies (MEA) [2] - Based on data from Zhi Shi Consulting, Hongji Chuangneng is projected to be the largest independent membrane electrode supplier in China and the second largest globally by sales volume in 2024 [2]

Group 1 - The core point of the article is that Hongji Chuangneng Technology's IPO application has expired after six months, with Haitong International and CITIC Securities serving as joint sponsors [1] - The company claims to be a global leader in independent membrane electrode supply, focusing on the R&D, mass production, and commercialization of catalyst-coated membranes (CCM) and membrane electrode assemblies (MEA) [2] - According to Zhi Shi Consulting, Hongji Chuangneng is the largest independent membrane electrode supplier in China and the second largest globally by sales volume in 2024 [2]